The concept of nanotechnology, while relatively nascent, is rapidly gaining traction. Recent research from institutions like Harvard and Tufts Universities has ushered in the age of “xenobots,” self-replicating organisms synthesized from stem cells. Their potential applications, from cancer cell mitigation to environmental preservation, are vast. 2023 might be the year when nanomedicine begins to reshape our approach to tackling complex diseases.

It’s something the healthcare in the US is focusing heavily on, and can perhaps be amplified by the recruitment of more specialist physicians and experts through companies like MASC medical – mascmedical.com – to focus on acquiring people with the expertise to advance the discovery.